Global orthopedic sales totaled $62 billion in 2024, an increase of 5% compared to 2023. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
Global orthopedic sales totaled $62 billion in 2024, an increase of 5% compared to 2023. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
Medacta is one of the largest and fastest-growing companies in orthopedics as it looks to expand its sports medicine footprint.
The company nearly doubled its sales quarter-over-quarter, increased its surgeon user base and reduced lead times.
Medacta is one of the largest and fastest-growing companies in orthopedics as it looks to expand its sports medicine footprint.
The company nearly doubled its sales quarter-over-quarter, increased its surgeon user base and reduced lead times.
The company’s base business grew 7% in the third quarter of 2025, driven by U.S. spine sales and offset by lagged enabling technology sales.
The company grew in the low double-digits, but volume headwinds caused Treace to revise its 2025 guidance downward.
The company grew in the double digits for the third quarter of 2025, driven by shoulder and international sales.
The company drove strong third quarter 2025 performance in the U.S. in both its spine and trauma businesses.
The company’s orthopedic business grew in the mid single digits in the third quarter of 2025 driven by an improving supply situation.
Stay up to date on the orthopedic market’s 3Q performance in 2025 as we update this post with company sales data and industry developments.
The company grew in the high single digits on a reported basis for the third quarter of 2025 and saw improved U.S. performance.
The company grew 30% in the third quarter of 2025 as it continues to take share from all major competitors in spine.
Excluding its divested spinal implant business, Stryker’s orthopedic sales grew in the double digits for the third quarter of 2025.
Customed’s cloud-based platform generates patient-specific surgical tools and implants through AI and automation with 3D printing, creating more precise orthopedic surgeries.
We surveyed sales performance outside the United States over the past several years for select orthopedic companies.
This latest round of funding strengthens Catalyst’s balance sheet as the company advances its commercial and clinical programs.
An overview of what is shaping the spine market, its leading players, geographic trends and our forecast for the next few years.
Login
Register for a free account
As a guest member you get access to more articles and videos every month.

